
Opinion|Videos|August 13, 2024
Legislative Support for Biosimilars
The expert panel discuss the importance of legislative support to continue innovations in the biosimilar space.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- In an ideal scenario, what would legislative support for biosimilars entail? Is it feasible in the near future for federal or state laws to promote or require that payers cover all biosimilars?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
2
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
3
'Tis the Season: SABCS 2025 to Highlight Latest Advances Across the Breast Cancer Continuum
4
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
5












































